Policy & Regulation2025-06-09 18:12:147Waters... noitazilaicremmoC dna tnempole Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists Policy & Regulation上一篇:Next's... remmus dna gnirps rof 'thgil d下一篇:What... ?otpyrc ni covah gnisuac ti siRelated Articles、 COVID... doof teerts lles ot srats erbiYou... tubed gnilzzad retfa tocsA layDark... noitasinoloc yb dekraps saw siTether... noillib 01$ pot slawardhtiw ni